- Home
- PFE
PFE
Pfizer Inc.
as 11-18-2025 3:36pm EST
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
| Founded: | 1849 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 141.3B | IPO Year: | N/A |
| Target Price: | $27.75 | AVG Volume (30 days): | 98.3M |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.73 | EPS Growth: | 131.89 |
| 52 Week Low/High: | $20.91 - $27.69 | Next Earning Date: | 11-04-2025 |
| Revenue: | $62,785,000,000 | Revenue Growth: | 3.89% |
| Revenue Growth (this year): | -0.19% | Revenue Growth (next year): | -0.68% |
Latest Pfizer Inc. News
PFE Breaking Stock News: Dive into PFE Ticker-Specific Updates for Smart Investing
Clinical Trials Arena
14 hours ago
Nuvalent aiming for approval on pivotal trial data for NSCLC candidate
The Wall Street Journal
15 hours ago
The Weight-Loss Craze Is About to Mint a Trillion-Dollar Company
![[Latest] Global NUT Midline Carcinoma Treatment Market Size/Share Worth USD 93.34 Billion by 2034 at a 15.26% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)](/cdn/transform/width=500,quality=90,format=webp/https://cdn.finquota.com/news/6d133940-da2f-4eb0-8bfe-52747b9432a8.png)
GlobeNewswire
17 hours ago
[Latest] Global NUT Midline Carcinoma Treatment Market Size/Share Worth USD 93.34 Billion by 2034 at a 15.26% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)
StockStory
a day ago
Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Pfizer (NYSE:PFE)
Barrons.com
a day ago
Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion
Motley Fool
a day ago
2 Giant Healthcare Stocks to Buy Hand Over Fist in November
Investor's Business Daily
a day ago
Johnson & Johnson Inks A $3.05 Billion Deal In Cancer Treatment
Zacks
2 days ago
MRK to Buy Cidara for $9.2B: Focus on Buyout Spree Heading Into 2026
Compare PFE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PFE Pfizer Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.